Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Afyonkarahisar
Clinical trial register · Turkey

Clinical Trials in Afyonkarahisar, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Istanbul 1988 Ankara 1440 Izmir 568 Adana 377 Antalya 261
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Afyonkarahisar Health Sciences University24 AstraZeneca6 Novo Nordisk A/S6 Boehringer Ingelheim2 Eli Lilly and Company2
Site location
Istanbul1988 Ankara1440 Izmir568 Adana377 Antalya261
All 318 locations
Target enrolment
to

Trials with a site in Afyonkarahisar

55 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Istanbul, Kayseri, Adana, Adapazarı/Turkiye, Afyonkarahisar, Ankara, Çanakkale/Türkiye, Eskişehir
2026-10-26
Not yet open
CBT-Based Stress Management Program for Healthcare Students
NCT07852117Stress (Psychology), Stress Management
Afyonkarahisar Health Sciences University
Not applicable
90
Afyonkarahisar
2026-10-20
Active, closed
Prediction of Chronic Disease Using Explainable Hybrid Machine Learning
NCT07845084Chronic Disease, Physical Activity
Afyonkarahisar Health Sciences University
Observational
268
Afyonkarahisar
2026-08-30
Not yet open
Afyonkarahisar Health Sciences University
Observational
250
Afyonkarahisar
2026-08-28
Recruiting
Novo Nordisk A/S
Phase 3
1,778
Kayseri, Adana, Adana /yüreği̇r, Adapazarı/Turkiye, Afyonkarahisar, Ankara, Gaziantep, Istanbul
2026-08-24
Not yet open
Pain After Diode Laser Frenectomy in Children
NCT07706023Abnormal Labial Frenum Frenectomy, Frenectomy
Afyonkarahisar Health Sciences University
Not applicable
53
Afyonkarahisar
2026-07-10
Recruiting
Ankara Yildirim Beyazıt University
Not applicable
54
Afyonkarahisar
2026-07-06
Recruiting
Medical Adhesive and Barrier Products for Preventing MARSI in Central Venous Catheter Dressings
NCT07697430Medical Adhesive Related Skin Injury, Central Venous Catheter
Azize Özdaş Gündoğan
Not applicable
162
Afyonkarahisar
2026-06-01
Not yet open
The Effect of Flipped Learning on Handwashing Skills
NCT07563361Surgical Hand Washing, Surgical Hand Washing Knowledge, Surgical Hand Washing Skills
Yeliz Ciğerci
Not applicable
128
Afyonkarahisar
2026-06
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Adana, Adapazarı/Sakarya, Afyonkarahisar, Altınordu/Ordu, Ankara, Antalya, Bayraklı/İzmir, Bursa
2026-05-11
Recruiting
Afyonkarahisar Health Sciences University
Not applicable
40
Afyonkarahisar
2026-04-15
Recruiting
Repetitive Transcranial Magnetic Stimulation in Cardiac Autonomic Dysfunction
NCT07482501Stroke, Autonomic Dysfunction, Hemiparesis
Afyonkarahisar Health Sciences University
Not applicable
44
Afyonkarahisar
2026-03-26
Recruiting
Afyonkarahisar Health Sciences University
Observational
30
Afyonkarahisar
2026-03-20
Not yet open
DETERMINATION OF THE EFFECTS OF STAINLESS STEEL CROWNS CEMENTED WITH RESIN CEMENTS ON INTERLEUKIN-10, 12, 18 LEVELS IN GINGIVAL CREVICULAR FLUID
NCT07421206Dental Caries, Gingival Inflammation, Periodontal Response to Dental Restorative Materials
Afyonkarahisar Health Sciences University
Not applicable
45
Afyonkarahisar
2026-02-16
By invitation
SELDA MERT
Not applicable
76
Afyonkarahisar
2026-02-16
Recruiting
Kutahya Health Sciences University
Not applicable
56
Afyonkarahisar
2026-02-01
Recruiting
Physiological and Biochemical Responses to Blood Flow Restriction Training
NCT07340385Healthy Individuals, Trained Athletes
Afyonkarahisar Health Sciences University
Observational
30
Afyonkarahisar
2026-01-20
Not yet open
Research and Treatment Society of Genetic Disorders
Observational
3,000
Konya, Afyonkarahisar, Ankara, Bursa, Denizli, Erzurum, Gaziantep, Giresun
2025-12-27
Recruiting
Afyonkarahisar Health Sciences University
Not applicable
78
Afyonkarahisar
2025-12-15
Recruiting
Eli Lilly and Company
Phase 3
7,140
Adana, Afyonkarahisar, Ankara, Antalya, Çanakkale, Çorum, Eskişehir, Istanbul
2025-12-01
Recruiting
TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%
NCT07279402NSCLC Stage IV, PD-L1 Gene Mutation, Atezolizumab, Real World Study
Antalya Training and Research Hospital
Observational
150
Adana, Afyonkarahisar, Ankara, Antalya, Aydin, Diyarbakır, Edirne, Gaziantep
2025-09-15
Recruiting
Amgen
Phase 3
12,800
Adana, Afyonkarahisar, Ankara, Antalya, Bursa, Denizli, Istanbul, Izmir
2025-07-25
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Adana, Afyonkarahisar, Ankara, Antalya, Bursa, Edirne, Istanbul, Izmir
2025-07-22
Active, closed
Assessment of Physical Performance in Children
NCT07107984Physical Performance
Afyonkarahisar Health Sciences University
Observational
200
Afyonkarahisar
2025-07-10
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Afyonkarahisar, Ankara, Çorum, Istanbul, Izmir, Kayseri, Kocaeli, Konya
2025-06-25
Active, closed
Arrowhead Pharmaceuticals
Phase 3
70
Afyonkarahisar, Bornova/Izmir, Melikgazi/Kayseri
2025-06-17
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
Adana, Afyonkarahisar, Ankara, Izmir, İzmit
2025-06-10
Recruiting
AstraZeneca
Phase 3
15,100
Afyonkarahisar, Ankara, Antalya, Çanakkale, Edirne, Istanbul, Izmir, Kayseri
2025-06-04
Active, closed
AstraZeneca
Phase 3
3,103
Adana, Afyonkarahisar, Ankara, Eskişehir, Izmir, Kocaeli, Odunpazari, Yenimahalle
2025-05-28
Recruiting
Pamukkale University
Not applicable
46
Afyonkarahisar
2025-05-01
Recruiting
Afyonkarahisar Health Sciences University
Not applicable
120
Afyonkarahisar
2025-03-19
Recruiting
AstraZeneca
Phase 3
11,300
Adana, Afyonkarahisar, Ankara, Antalya, Eskişehir, Istanbul, Izmir, Kahramanmaraş
2025-03-14
Active, closed
Evaluation of the Clinical Success of Hydrophilic Fissure Sealants
NCT07262502Pit and Fissure Caries (Disorder), Pit and Fissure Sealants
Afyonkarahisar Health Sciences University
Not applicable
250
Afyonkarahisar
2025-03-01
Not yet open
Afyonkarahisar Health Sciences University
Not applicable
120
Afyonkarahisar
2025-02-12
Recruiting
The Effects of Whirlpool and Contrast Bath in Patients with Complex Regional Pain Syndrome After Distal Radius Fracture
NCT06769373Distal Radius Fracture, Complex Regional Pain Syndrome Type I, Complex Regional Pain Syndrome
Afyonkarahisar Health Sciences University
Not applicable
40
Afyonkarahisar
2025-01-31
Recruiting
Afyonkarahisar Health Sciences University
Not applicable
63
Afyonkarahisar
2024-12-16
Recruiting
The Effect of Hypnosis on Periodontal Treatment
NCT06808373Peridontal Disease, Dental Anxiety
Afyonkarahisar Health Sciences University
Not applicable
50
Afyonkarahisar
2024-11-18
Recruiting
Validity and Reliability of the PRAFAB
NCT07339657Urinary Incontinence
Afyonkarahisar Health Sciences University
Observational
63
Afyonkarahisar
2024-10-15
Active, closed
Afyonkarahisar Health Sciences University
Not applicable
20
Afyonkarahisar
2024-08-01
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Ankara, Istanbul, Eskişehir, Afyonkarahisar, Antalya, Bursa, Edirne, Kayseri
2024-06-25
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Adana, Afyonkarahisar, Ankara, Elâzığ, Erzurum, Eskişehir, Gaziantep, Istanbul
2024-06-17
Active, closed
Eli Lilly and Company
Phase 3
10,000
Afyonkarahisar, Ankara, Antalya, Bornova, Çorum, Edirne, Eskişehir, Gaziantep
2024-04-30
Active, closed
Novo Nordisk A/S
Phase 3
673
Eskişehir, Adana, Afyonkarahisar, Ankara, Bursa, Edirne, Istanbul, Kayseri
2024-04-01
Active, closed
AstraZeneca
Phase 3
2,554
Adana, Adapazarı, Afyonkarahisar, Ankara, Antalya, Bursa, Istanbul, Kahramanmaraş
2024-03-29
Active, closed
Afyonkarahisar Health Sciences University
Observational
32
Afyonkarahisar
2024-03-15
Recruiting
AstraZeneca
Phase 3
5,250
Adana, Afyonkarahisar, Antalya, Bursa, Çanakkale, Çankaya, Isparta, Istanbul
2024-02-21
Recruiting
Comparison of Ultrasound-Guided Injection With Median Nerve Decompression Surgery in Carpal Tunnel Syndrome
NCT06243848Musculoskeletal Diseases, Median Nerve Disease, Carpal Tunnel Syndrome, Ultrasound-Guided Injection
Afyonkarahisar Health Sciences University
Not applicable
60
Afyonkarahisar
2024-01-25
Recruiting
Murat Akın
Observational
80
Afyonkarahisar
2023-12-01
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Afyonkarahisar, Ankara, Antalya, Istanbul, Izmir, Kayseri, Mersin, Samsun
2023-04-11
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Ankara, Istanbul, Eskişehir, Bursa, Adana, Afyonkarahisar, Edirne, Izmir
2023-03-01
Recruiting
The Relationship Between Ultrasonographic Findings and Sleep Quality in Carpal Tunnel Syndrome
NCT05742776Musculoskeletal Diseases, Median Nerve Disease, Carpal Tunnel Syndrome, Ultrasound
Afyonkarahisar Health Sciences University
Observational
120
Afyonkarahisar
2023-02-23
Recruiting
Transcranial Magnetic Stimulation Therapy in Neuropathic Painful Spinal Cord Injury Patients
NCT05645003Spinal Cord Injuries, Neuropathic Pain, Neurological Diseases or Conditions
Afyonkarahisar Health Sciences University
Not applicable
60
Afyonkarahisar
2022-11-15
Active, closed
Ultrasonograpy in Hemiplegic Patients
NCT06706063Hemiplegia, Hemiparesis After Stroke, Spasticity
Afyonkarahisar Health Sciences University
Observational
100
Afyonkarahisar
2022-04-15
Active, closed
Noema Pharma AG
Phase 2/3
166
Düzce, Selçuklu, Afyonkarahisar, Bursa, Istanbul, Kocaeli, Mersin
2022-01-11
By invitation
Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction
NCT04798430Cardiovascular Disease With Mention of Arteriosclerosis, Elevated Cholesterol, Familial Hypercholesterolemia
DrugLerodalcibep
LIB Therapeutics LLC
Phase 3
2,000
Izmir, Afyonkarahisar
2020-12-03
Rows per page Showing 1–55 of 55
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/afyonkarahisar

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 55 of those studies with a site in Afyonkarahisar.

How many clinical trials are recruiting in Afyonkarahisar?

29 of the 55 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 8 have not yet opened recruitment, 16 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Afyonkarahisar), 55 studies
PhaseStudiesRecruitingShare
Not applicable211338.2%
Phase 3211038.2%
Observational12621.8%
Phase 2/3101.8%

Most active sponsors

Lead sponsors with the most studies (Afyonkarahisar)
Lead sponsorStudiesRecruiting
Afyonkarahisar Health Sciences University2413
AstraZeneca63
Novo Nordisk A/S62
Amgen22
Boehringer Ingelheim22
Eli Lilly and Company21
Ankara Yildirim Beyazıt University11
Antalya Training and Research Hospital11
Arrowhead Pharmaceuticals10
Azize Özdaş Gündoğan11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.